U.S. Markets closed

Acadia: 2Q Earnings Snapshot

SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported a loss of $54.9 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 38 cents.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.

The drugmaker posted revenue of $83.2 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $73.1 million.

Acadia shares have risen 52% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $24.58, a rise of 63% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD